< Retour aux actualités
Olmix carried out a refinancing to support its strong growth ambitions

Olmix carried out a refinancing to support its strong growth ambitions

1 April 2022

Olmix – a worldwide specialist of natural solutions for agriculture – carried out a structuring refinancing that will provide the Group with additional resources to accelerate its development.

In October 2020, Motion Equity Partners and Amadéite (the holding company of the founder) acquired a majority stake in Olmix, a specialist of natural solutions for sustainable agriculture. Since the entry, the Group put in place a new governance and a clear roadmap for growth that successfully led to strong topline.

On the back of a dynamic growth, Olmix successfully carried out a refinancing with the issuance of a Unitranche debt facility from Bridgepoint Credit.

The new debt facility will provide the Group with additional resources to deliver its strong growth ambitions in dynamic markets, in particular the deployment of a Buy & Build strategy. This very competitive debt provides the Group with important acquisition lines and includes an ESG ratchet to reward Olmix for its positive impact on the environment.

“Olmix is an innovative biotech that has established itself as one of the reference players to contribute to the development of sustainable agriculture. This refinancing is a key milestone in our project: it will provide Olmix with additional means to capture the full potential of the Group, notably through targeted M&A. The ESG ratchet agreed with Bridgepoint Credit will reward Olmix for its positive impact on the environment.” declared Patrick Eisenchteter, Managing Partner at Motion Equity Partners.

 About Olmix

Olmix is a group specialized in natural solutions for agriculture, offering sustainable alternatives to chemical and pharmaceutical inputs, realizing +160m€ Sales. Founded in 1995 in Brittany, the Group has turned into one of the world specialists of marine biotechnologies and green chemistry, thanks to its unique expertise in valuing and transforming algae resulting from multiple R&D investments.

Through the development of innovative and recognized natural solutions (based on algae, trace elements, clays and organic matters), the Group supports farmers, breeders and agricultural distribution chains in adapting production models. It addresses two main markets:

  • “Animal Care”: solutions to improve animal welfare, nutrition & health, and thus reduce the use of antibiotics and chemical additives;
  • “Plant Care”: solutions to improve soil structure and plant nutrition & health, and thus reduce the use of chemicals.

Olmix’s products are sold in more than 100 countries worldwide through distributors and cooperatives. The Company benefits from a network of 28 implantations and employs 650 people.